Technology, data and innovation have significantly modified and digitized many of the world’s core industries, from retail to banking, sport to travel. These digital transformations have created platforms for better cost efficiencies, more mobility and greater consumer focus. Yet despite ageing populations and traditional healthcare costs continuing to rise, the health and healthcare industries have been slow in their uptake of a digital agenda.
The industry is now seeing a rapidly growing array of innovative technologies and applications which are starting to grab consumer attention especially as the larger, more established corporations move into this space. These advancements are showing that 2015 is set to be what many commentators are viewing, as the industry ‘take-off’ year, inevitably giving rise to greater investment and business opportunities.
However, the map showing the path to healthcare’s effective digital transformation is not entirely clear and small tech companies and venture capitalists still dominate the market. Commercial business models, reimbursement methods and market-wide consumer acceptance still need to be identified and proven and as with other industries before digital health, regulation will undoubtedly play a key role in allowing this to happen.
The FT Digital Health Summit USA will build upon its unique expertise and knowledge of healthcare, life sciences and digital business to set out a stakeholder roadmap for the successful transition of America’s digital health industry, which in terms of investment, innovation and market share is a long way ahead compared with other regions. Key figures from pharmaceutical companies, technology corporations, investment platforms, healthcare providers, life science multinationals and regulation will come together to set the agenda for overcoming the barriers towards a sustainable digital transition in the US healthcare system.
